RT3 is a synthetic peptide engineered as a single-molecule triple agonist of the GLP-1, GIP, and glucagon receptors. It is a recognised reference compound in incretin and triple-agonist research. Synthetic peptide, supplied lyophilised. Available in 10 mg and 20 mg vials, sealed and labelled with lot identifier. Storage: between 2°C and 8°C before reconstitution. For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.